Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
33 hedge funds and large institutions have $6.02M invested in Bio-Path Holdings Inc in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 18 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
23% less funds holding
Funds holding: 43 → 33 (-10)
56% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 18
62% less capital invested
Capital invested by funds: $16.1M → $6.02M (-$10M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Legal & General Group
London,
United Kingdom
|
+$912K |
| 2 |
Millennium Management
New York
|
+$520K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$264K |
| 4 |
ECM
Element Capital Management
New York
|
+$208K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$170K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.99M |
| 2 |
State Street
Boston,
Massachusetts
|
-$568K |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$327K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$302K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$245K |
BPTH Hedge Fund Activity: Q2 2017 in Review
33 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q2 2017, worth a combined $6.02M — down 62% from $16.1M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of BPTH and 8 opened new positions — a net loss of 10 holders — while 10 trimmed existing stakes and 8 added.
The largest buyer was Legal & General Group, adding an estimated $912K. The largest seller was BlackRock, cutting an estimated $1.99M.
- 33 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q2 2017, down from 43 in Q1 2017.
- Funds reported $6.02M of Bio-Path Holdings Inc stock for Q2 2017, down 62% quarter-over-quarter.
- 8 funds opened new Bio-Path Holdings Inc positions in Q2 2017 and 18 closed out, a net change of -10 holders.
- The largest Bio-Path Holdings Inc buyer in Q2 2017 was Legal & General Group, an estimated $912K added.
- The largest Bio-Path Holdings Inc seller in Q2 2017 was BlackRock, an estimated $1.99M sold.
Based on aggregated 13F filings for Q2 2017.